Browsing Tag
Aarti Drugs Limited
7 posts
Aarti Drugs (NSE: AARTIDRUGS) profit climbs 29% in Q2 FY26 as export-led growth drives margin gains
Aarti Drugs posts 29% YoY profit growth in Q2 FY26 on rising exports and cost discipline. See how backward integration is boosting its margin outlook.
Can U.S. tariffs on Chinese APIs fast-track Aarti Drugs’ export market growth in 2025?
U.S. tariffs on Chinese APIs could benefit Aarti Drugs in 2025. Can Sayakha and Tarapur expansions help it capture regulated-market export growth?
Aarti Drugs Q1 FY26 results: Can greenfield expansions and U.S. tariff shifts drive sustained margin growth?
Aarti Drugs Q1 FY26 PAT jumps 62% YoY as greenfield expansions and U.S. tariff shifts open new export opportunities. Can margins sustain?
Aarti Drugs soars with Q4 FY25 profit spike—But what’s behind the full-year revenue drop?
Aarti Drugs Q4 FY25 profit rose 33% YoY as exports rebounded, but full-year revenue declined 5%. See what’s behind the surge—and the challenges ahead.
Aarti Drugs faces revenue decline amid API Market challenges in Q3 FY25
Aarti Drugs Limited, a Mumbai-based pharmaceutical company engaged in Active Pharmaceutical Ingredients (API), formulations, specialty chemicals, and intermediates,…
Aarti Drugs launches dermatology product production at new Tarapur facility
Aarti Drugs Limited (NSE: AARTIDRUGS; BSE:524348), a Mumbai-based pharmaceutical powerhouse, has officially announced the start of its dermatology…
Aarti Drugs Limited announces 6% YoY revenue growth in Q1 FY24
For the quarter ending 30th June 2023, Mumbai-based pharmaceutical company, Aarti Drugs Limited, announced its audited financial results,…